Green Nail in a Patient With Psoriasis Receiving Deucravacitinib
Yoshihito Mima, Tsutomu Ohtsuka, Yuta Norimatsu · 2024
Read Green Nail in a Patient With Psoriasis Receiving Deucravacitinib by Yoshihito Mima, Tsutomu Ohtsuka, Yuta Norimatsu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11739536.txt.
Description
Yoshihito Mima, Tsutomu Ohtsuka, and Yuta Norimatsu report a green nail in a man taking a psoriasis drug, in a case report published in twenty twenty-four. Green nail usually comes from a common bacterium and favors damaged nails, psoriatic nails, or hands kept wet. The drug, deucravacitinib, blocks a signaling enzyme and clears psoriasis well.
The patient, a man of seventy-two, developed the green nail four months into treatment. His nails had shown no psoriasis before the drug began, so the team suspects the drug played a part. They trace a possible route: the blocked enzyme carries signals for a protein that helps fight this bacterium. No earlier case tied the drug to green nail. The report asks clinicians to watch for it.
Catalog record
| CREATOR | Yoshihito Mima, Tsutomu Ohtsuka, Yuta Norimatsu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |